Matches in Nanopublications for { ?s ?p "[Enrolled in the study were 203 patients with chronic active hepatitis C. They were all given: interferon alpha-2a (3 MU subcutaneously thrice a week) and ursodeoxycholic acid (10 mg/kg/day) for 9 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP904552.RAarWFMYI8k4VnZuRchRUltafRN5eAY43RyvK_KqcENIE130_assertion description "[Enrolled in the study were 203 patients with chronic active hepatitis C. They were all given: interferon alpha-2a (3 MU subcutaneously thrice a week) and ursodeoxycholic acid (10 mg/kg/day) for 9 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904552.RAarWFMYI8k4VnZuRchRUltafRN5eAY43RyvK_KqcENIE130_provenance.
- assertion description "[Enrolled in the study were 203 patients with chronic active hepatitis C. They were all given: interferon alpha-2a (3 MU subcutaneously thrice a week) and ursodeoxycholic acid (10 mg/kg/day) for 9 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP294330.RAf49Mbz3gMWwR1oioU37RiuZG5LuBw9Sn5WIknAU3tpI130_assertion description "[Enrolled in the study were 203 patients with chronic active hepatitis C. They were all given: interferon alpha-2a (3 MU subcutaneously thrice a week) and ursodeoxycholic acid (10 mg/kg/day) for 9 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294330.RAf49Mbz3gMWwR1oioU37RiuZG5LuBw9Sn5WIknAU3tpI130_provenance.
- NP477306.RAt-QhW2_Wk7DbRN2z7Cs8cwgzkeEmBnEBCOen320M5hU130_assertion description "[Enrolled in the study were 203 patients with chronic active hepatitis C. They were all given: interferon alpha-2a (3 MU subcutaneously thrice a week) and ursodeoxycholic acid (10 mg/kg/day) for 9 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477306.RAt-QhW2_Wk7DbRN2z7Cs8cwgzkeEmBnEBCOen320M5hU130_provenance.
- NP294329.RA1jTPsb_QPfVoMlUvKS8133WWB4WMfj3DEtUw5mLDgJw130_assertion description "[Enrolled in the study were 203 patients with chronic active hepatitis C. They were all given: interferon alpha-2a (3 MU subcutaneously thrice a week) and ursodeoxycholic acid (10 mg/kg/day) for 9 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294329.RA1jTPsb_QPfVoMlUvKS8133WWB4WMfj3DEtUw5mLDgJw130_provenance.